Oncoclínicas: What’s Next After Last Week’s Stock Surge?

Oncoclínicas (ONCO3) grabbed the attention of the Brazilian stock exchange last week. The stock soared over 20% in a single session. This spike followed the announcement of a R$1.5 billion ($290 million) capital increase. Banco Santander reinforced its outperform rating (equivalent to a buy) on the stock, citing positive asymmetry. Santander’s analysis presented two scenarios. […]

Leave a Reply

Your email address will not be published. Required fields are marked *